Skip to main content

Table 1 Distribution of the clinical status of patients in this study

From: microRNA expression pattern as an ancillary prognostic signature for radiotherapy

 

Before radiation

Screening set (n = 8)

Training set (n = 38)

Poor response

Response

P

Poor response

Response

P

N

Mean

SD

N

Mean

SD

N

Mean

SD

N

Mean

SD

Typeb

 H&N

2

  

2

  

1

8

  

17

  

0.69

 Colorectal

2

  

2

   

5

  

8

   

Agea

4

69.75

16.24

4

62

16.81

0.52

13

61.54

15.03

25

61.08

15.21

0.93

Sexb

 Female

1

  

1

  

1

6

  

13

  

0.732

 Male

3

  

3

   

7

  

12

   

Stageb

 I

1

  

1

  

0.23

1

  

4

  

0.111

 II

0

  

2

   

0

  

6

   

 III

3

  

1

   

4

  

8

   

 IV

0

  

0

   

8

  

7

   

Total dosagea (Gy)

3

63.87

11.68

4

60.25

11.37

0.69

13

66.18

7.58

24

63.61

9.29

0.398

Chemotherapyb

4

  

4

  

1

13

  

25

  

0.728

 

Before radiation

Testing (n = 24)

Poor response

Response

P

N

Mean

SD

N

Mean

SD

Typeb

 H&N

1

  

10

  

0.902

 Colorectal

1

  

12

   

Agea

2

69.5

9.19

22

54.45

11.99

0.1

Sexb

 Female

2

  

15

  

0.343

 Male

0

  

7

   

Stageb

 I

0

  

3

  

0.081

 II

0

  

6

   

 III

0

  

8

   

 IV

2

  

5

   

Total dosagea (Gy)

2

60.2

13.86

22

58.03

14.7

0.843

Chemotherapyb

2

  

22

  

0.577

 

After radiation

Screening set (n = 7)

Training set (n = 31)

Poor response

Response

P

Poor response

Response

P

N

Mean

SD

N

Mean

SD

N

Mean

SD

N

Mean

SD

Typeb

 H&N

2

  

2

  

0.66

7

  

15

  

0.94

 Colorectal

1

  

2

   

3

  

6

   

Agea

3

62.67

9.71

4

62

16.81

0.95

10

58.6

13.23

21

60.29

14.73

0.75

Sexb

 Female

1

  

1

  

0.81

5

  

11

  

0.9

 Male

2

  

3

   

5

  

10

   

Stageb

 I

0

  

1

  

0.14

0

  

3

  

0.042*

 II

0

  

2

   

0

  

5

   

 III

3

  

1

   

2

  

7

   

 IV

0

  

0

   

8

  

6

   

Total dosagea (Gy)

2

70.6

0.85

4

60.25

11.37

0.29

10

66.88

6.63

20

64.28

9.01

0.43

Chemotherapyb

3

  

4

  

0.81

10

  

21

  

0.36

 

After radiation

Testing (n = 24)

 

Poor response

Response

P

N

Mean

SD

N

Mean

SD

 

Typeb

 H&N

1

  

10

  

0.902

 Colorectal

1

  

12

   

Agea

2

69.5

9.19

22

54.45

11.99

0.1

Sexb

 Female

2

  

15

  

0.343

 Male

0

  

7

   

Stageb

 I

0

  

3

  

0.081

 II

0

  

6

   

 III

0

  

8

   

 IV

2

  

5

   

Total dosagea (Gy)

2

60.2

13.86

22

58.03

14.7

0.843

Chemotherapyb

2

  

22

  

0.577

  1. Each groups were well matched for age, gender. Mean, average of each samples
  2. SD standard deviation, M male, F female
  3. *P value < 0.05
  4. aIndependent samples test
  5. bPearson Chi Square